Aliases & Classifications for Leiomyoma

MalaCards integrated aliases for Leiomyoma:

Name: Leiomyoma 12 74 54 43 15
Leiomyomatous Neoplasm 12
Leiomyomatous Tumor 12
Uterine Fibroids 71
Fibroid Tumor 71
Leiomyomas 15

Classifications:



External Ids:

Disease Ontology 12 DOID:127
MeSH 43 D007889
NCIt 49 C3157
SNOMED-CT 67 702978006
UMLS 71 C0023267 C0042133

Summaries for Leiomyoma

Disease Ontology : 12 A cell type benign neoplasm that is a benign tumor of smooth muscle cells.

MalaCards based summary : Leiomyoma, also known as leiomyomatous neoplasm, is related to bizarre leiomyoma and cellular leiomyoma, and has symptoms including pelvic pain An important gene associated with Leiomyoma is HMGA2 (High Mobility Group AT-Hook 2), and among its related pathways/superpathways are Gastric cancer and Pathways in cancer. The drugs Anastrozole and Dienogest have been mentioned in the context of this disorder. Affiliated tissues include uterus, smooth muscle and breast, and related phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and cellular

Wikipedia : 74 A leiomyoma, also known as fibroids, is a benign smooth muscle tumor that very rarely becomes cancer... more...

Related Diseases for Leiomyoma

Diseases related to Leiomyoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 871, show less)
# Related Disease Score Top Affiliating Genes
1 bizarre leiomyoma 34.7 PGR MED12 FH ESR1 ACTC1
2 cellular leiomyoma 34.6 MED12 DES
3 lung leiomyoma 34.5 PGR ESR1
4 leiomyoma cutis 34.4 MED12 FH
5 leiomyoma, uterine 34.3 TGFB3 RAD51B PGR MED12 HMGA2 GNRH1
6 breast leiomyoma 34.2 PGR FH CD34
7 orbital leiomyoma 34.2 S100A1 GNRH1
8 vulvar leiomyoma 34.1 PGR HMGA2 ESR1 CD34
9 benign metastasizing leiomyoma 34.0 VIM PGR DES CYP19A1 ACTC1
10 deep leiomyoma 33.8 KIT CD34
11 hereditary leiomyomatosis and renal cell cancer 33.7 PTCH1 FH
12 gastric leiomyoma 33.7 KIT FH
13 gallbladder leiomyoma 33.6 KIT CD34
14 small intestine leiomyoma 33.4 PTCH1 KIT CD34
15 liver leiomyoma 33.4 PGR KIT ESR1 CD34
16 subserous uterine fibroid 33.4 PGR CYP19A1
17 endobronchial leiomyoma 33.1 KIT CD34
18 leiomyomatosis 32.2 PGR MED12 KIT GNRH1 FH ESR1
19 leiomyosarcoma 32.0 VIM S100A1 PGR MED12 KIT HMGA2
20 myofibroma 31.9 S100A1 DES CD34
21 gastrointestinal stromal tumor 31.8 VIM S100A1 KIT DES CD34 ACTC1
22 intravenous leiomyomatosis 31.6 PGR MED12 HMGA2 ESR1 DES CD34
23 adenomyosis 31.5 PGR GNRH1 ESR2 ESR1 CYP19A1
24 endometriosis 31.4 PGR GNRH1 ESR2 ESR1 CYP19A1
25 diffuse peritoneal leiomyomatosis 31.3 PGR MED12 GNRH1
26 infertility 31.3 PGR GNRH1 ESR2 CYP19A1
27 spindle cell sarcoma 31.2 VIM DES CD34 ACTC1
28 ovarian cyst 31.2 GNRH1 ESR2 CYP19A1
29 lymphangioleiomyomatosis 31.2 PGR GNRH1 ESR1 DES
30 pleomorphic lipoma 31.1 PGR HMGA2 CD34
31 prostatic hypertrophy 31.1 PGR ESR1 CYP19A1
32 vaginal discharge 31.1 PGR GNRH1 ESR1 CYP19A1
33 rare tumor 31.1 KIT DES ACTC1
34 endometrial hyperplasia 31.0 PGR ESR2 ESR1 CYP19A1
35 fibroma 30.9 VIM S100A1 PTCH1 DES CD34 ACTC1
36 fibromatosis 30.9 VIM DES ACTC1
37 mesenchymal cell neoplasm 30.9 KIT HMGA2 CD34
38 in situ carcinoma 30.8 PGR ESR1 CYP19A1
39 pneumothorax 30.8 VIM PGR GNRH1 ACTC1
40 granular cell tumor 30.8 VIM S100A1 DES
41 myxoid leiomyosarcoma 30.8 PGR ACTC1
42 liposarcoma 30.7 VIM HMGA2 DES CD34
43 adenomyoma 30.7 PGR MED12 GNRH1 ESR1
44 malignant mesenchymoma 30.7 DES CD34
45 endometrial adenocarcinoma 30.6 VIM PGR ESR2 ESR1
46 meningioma, familial 30.6 PTCH1 PGR ESR1 CD34
47 pleomorphic adenoma 30.6 VIM S100A1 HMGA2 DES ACTC1
48 myoma 30.6 PGR MED12 KIT HMGA2 GNRH1 FH
49 leydig cell tumor 30.6 GNRH1 ESR1 CYP19A1
50 pelvic organ prolapse 30.6 PGR ESR2 ESR1
51 bartholin's gland benign neoplasm 30.6 PGR ESR1
52 infantile digital fibromatosis 30.5 VIM DES
53 epithelioid leiomyosarcoma 30.5 VIM PGR DES ACTC1
54 lymphangioma 30.5 VIM CD34 ACTC1
55 endometriosis of ovary 30.5 PGR GNRH1 ESR2 ESR1 CYP19A1
56 gynecomastia 30.4 PGR GNRH1 ESR2 ESR1 CYP19A1
57 sarcoma 30.4 VIM S100A1 KIT DES ACTC1
58 breast myofibroblastoma 30.4 ESR1 CD34
59 cystadenocarcinoma 30.4 VIM PGR ESR2 ACTC1
60 cutaneous fibrous histiocytoma 30.4 VIM S100A1 DES CD34 ACTC1
61 estrogen excess 30.3 PGR GNRH1 ESR2 ESR1 CYP19A1
62 sertoli cell tumor 30.3 VIM PGR CYP19A1
63 breast fibroadenoma 30.3 PGR MED12 HMGA2 ESR1 CYP19A1 CD34
64 embryonal rhabdomyosarcoma 30.3 PTCH1 DES ACTC1
65 breast disease 30.3 PGR ESR2 ESR1 CYP19A1
66 cutaneous leiomyosarcoma 30.3 VIM FH DES ACTC1
67 glomus tumor 30.3 VIM S100A1 DES CD34 ACTC1
68 cystadenoma 30.2 PGR KIT FH
69 chondroid lipoma 30.2 HMGA2 CD34
70 glomangiomyoma 30.2 VIM CD34 ACTC1
71 lipomatosis, multiple 30.2 KIT HMGA2 DES CD34
72 breast adenocarcinoma 30.2 PGR MED12 HMGA2 ESR1
73 hemangioma 30.2 PGR KIT CD34 ACTC1
74 pituitary adenoma, prolactin-secreting 30.2 HMGA2 GNRH1 ESR2 ESR1
75 breast ductal carcinoma 30.2 PGR ESR2 ESR1 CYP19A1
76 disorders of sexual development 30.2 GNRH1 ESR2 ESR1 CYP19A1
77 reticulum cell sarcoma 30.2 VIM S100A1 DES ACTC1
78 renal cell carcinoma, nonpapillary 30.1 VIM TGFB3 S100A1 KIT FH ACTC1
79 fasciitis 30.1 VIM ESR1 CD34 ACTC1
80 teratoma 30.1 VIM KIT ESR1 ACTC1
81 male infertility 30.1 GNRH1 ESR2 ESR1 CYP19A1
82 neurilemmoma 30.0 VIM S100A1 KIT DES CD34 ACTC1
83 smooth muscle tumor 30.0 VIM S100A1 PGR MED12 KIT HMGA2
84 connective tissue benign neoplasm 30.0 PTCH1 KIT CD34
85 angiosarcoma 29.9 VIM KIT CD34
86 nephroma 29.9 PGR KIT DES ACTC1
87 perivascular epithelioid cell tumor 29.9 PGR KIT DES ACTC1
88 neurofibroma 29.9 VIM S100A1 KIT CD34 ACTC1
89 fibrosarcoma 29.8 VIM KIT DES ACTC1
90 endometrial stromal sarcoma 29.8 VIM PGR KIT ESR2 ESR1 DES
91 embryonal sarcoma 29.8 VIM KIT DES
92 hemangiopericytoma, malignant 29.8 VIM KIT DES CD34 ACTC1
93 desmoid tumor 29.7 KIT DES CD34 ACTC1
94 angiomyolipoma 29.7 VIM S100A1 PGR KIT ESR1 DES
95 retroperitoneal leiomyosarcoma 29.7 KIT CD34
96 chondroma 29.7 S100A1 KIT HMGA2 ACTC1
97 carcinosarcoma 29.6 VIM S100A1 PGR KIT DES ACTC1
98 pleomorphic carcinoma 29.6 VIM PGR KIT
99 benign breast phyllodes tumor 29.5 VIM PGR MED12 KIT
100 cryptorchidism, unilateral or bilateral 29.5 KIT GNRH1 ESR2 ESR1 CYP19A1
101 well-differentiated liposarcoma 29.5 KIT HMGA2 CD34
102 renal oncocytoma 29.5 VIM S100A1 KIT
103 rhabdomyosarcoma 29.5 VIM PTCH1 KIT DES ACTC1
104 malignant fibrous histiocytoma 29.4 VIM KIT DES ACTC1
105 oncocytoma 29.4 VIM S100A1 KIT FH
106 breast malignant phyllodes tumor 29.3 PGR MED12 KIT ESR1 CD34
107 wilms tumor 1 29.3 PGR MED12 KIT ESR1 CD34
108 sarcoma, synovial 29.2 VIM KIT HMGA2 DES CD34
109 fibrous histiocytoma 29.2 VIM KIT DES CD34 ACTC1
110 medulloblastoma 29.2 VIM PTCH1 KIT ESR2 DES ACTC1
111 inflammatory myofibroblastic tumor 29.2 VIM KIT DES CD34 ACTC1
112 cavernous hemangioma 29.1 VIM S100A1 KIT DES CD34
113 retroperitoneal sarcoma 29.1 KIT CD34
114 ovarian cancer 29.0 VIM TGFB3 RAD51B PGR KIT HMGA2
115 dermatofibrosarcoma protuberans 28.9 VIM S100A1 KIT HMGA2 DES CD34
116 uterine corpus bizarre leiomyoma 12.4
117 uterine corpus apoplectic leiomyoma 12.4
118 bladder leiomyoma 12.3
119 urethra leiomyoma 12.3
120 uterus interstitial leiomyoma 12.3
121 prostate leiomyoma 12.3
122 colon leiomyoma 12.3
123 ureter leiomyoma 12.3
124 trachea leiomyoma 12.3
125 esophagus leiomyoma 12.3
126 fallopian tube leiomyoma 12.3
127 leiomyoma of vulva and esophagus 12.2
128 appendix leiomyoma 12.2
129 larynx leiomyoma 12.2
130 vagina leiomyoma 12.2
131 rectum leiomyoma 12.2
132 mediastinum leiomyoma 12.2
133 dartoic leiomyoma 12.2
134 extrahepatic bile duct leiomyoma 12.1
135 central nervous system leiomyoma 12.1
136 large bowel leiomyoma 12.1
137 uterine corpus epithelioid leiomyoma 12.1
138 uterine corpus dissecting leiomyoma 12.1
139 uterine corpus myxoid leiomyoma 12.1
140 anus leiomyoma 12.1
141 pericardium leiomyoma 12.1
142 uterine corpus cellular leiomyoma 12.1
143 angiomyoma 12.1
144 submucous uterine fibroid 11.7
145 renal cell carcinoma, papillary, 1 11.5
146 bladder benign neoplasm 11.2
147 glassy cell carcinoma of the cervix 10.7 PGR ESR1
148 bartholin's gland adenoid cystic carcinoma 10.7 PGR ESR1
149 chronic tympanitis 10.7 PGR ESR1
150 bartholin's gland adenoma 10.7 PGR ESR1
151 granulomatous endometritis 10.7 PGR ESR1
152 vestibular gland benign neoplasm 10.7 PGR ESR1
153 infertility due to extratesticular cause 10.7 GNRH1 ESR1
154 fat necrosis of breast 10.7 HMGA2 ESR1
155 uterine corpus adenosarcoma 10.7 PGR ESR1
156 vaginal glandular tumor 10.7 PGR ESR1
157 calcifying aponeurotic fibroma 10.7 PGR ACTC1
158 vulvar syringoma 10.7 PGR ESR1
159 trigonitis 10.7 PGR ESR1
160 fibroblastic rheumatism 10.7 DES ACTC1
161 breast scirrhous carcinoma 10.7 PGR ESR1
162 oncocytic breast carcinoma 10.7 PGR ESR1
163 cervical clear cell adenocarcinoma 10.7 PGR ESR1
164 adult type testicular granulosa cell tumor 10.7 PGR ESR1
165 ovarian seromucinous carcinoma 10.7 PGR ESR1
166 glycogen-rich clear cell breast carcinoma 10.7 PGR ACTC1
167 breast papillary carcinoma 10.7 PGR ESR1
168 lymphangiectasis 10.7 VIM ACTC1
169 primitive neuroectodermal tumor of the cervix uteri 10.6 VIM DES
170 peritoneal benign neoplasm 10.6 PGR MED12 GNRH1
171 nonmucinous bronchioloalveolar adenocarcinoma 10.6 ESR2 ESR1
172 intravascular papillary endothelial hyperplasia 10.6 VIM ACTC1
173 comedo carcinoma 10.6 PGR ESR1
174 breast metaplastic carcinoma 10.6 PGR ESR1
175 mammographic density 10.6 PGR ESR1 CYP19A1
176 endometrial mucinous adenocarcinoma 10.6 VIM PGR
177 lymphangiomatosis 10.6 VIM PGR DES
178 hypertrophy of breast 10.6 PGR ESR1 CYP19A1
179 congenital epulis 10.6 VIM PGR DES
180 epulis 10.6 VIM PGR DES
181 bile duct cystadenoma 10.6 ESR2 ESR1
182 pulmonary vein leiomyosarcoma 10.6 PGR CD34
183 progesterone resistance 10.6 PGR ESR2 ESR1
184 lung meningioma 10.6 PGR CD34
185 vaginal cancer 10.6 PGR ESR2 ESR1
186 myoepithelial carcinoma 10.6 VIM HMGA2 ACTC1
187 premenstrual tension 10.6 PGR GNRH1
188 endocervical carcinoma 10.6 VIM PGR ESR1
189 breast myoepithelial carcinoma 10.6 VIM PGR ACTC1
190 ectomesenchymoma 10.6 S100A1 HMGA2 DES
191 lipid-rich carcinoma 10.6 PGR ESR1
192 ewing sarcoma of bone 10.6 VIM DES
193 aromatase deficiency 10.6 GNRH1 ESR1 CYP19A1
194 luminal breast carcinoma a 10.6 PGR ESR1 CYP19A1
195 ischemic fasciitis 10.6 S100A1 DES ACTC1
196 infiltrating lipoma 10.6 HMGA2 CD34
197 botryoid rhabdomyosarcoma 10.6 DES ACTC1
198 peritoneal mesothelioma 10.6 VIM PGR ESR1
199 endocervical adenocarcinoma 10.6 VIM PGR ESR1
200 papillary tumor of the pineal region 10.6 VIM S100A1
201 rhabdoid tumor predisposition syndrome 1 10.6 VIM DES ACTC1
202 postmenopausal atrophic vaginitis 10.6 ESR2 ESR1 CYP19A1
203 estrogen-receptor negative breast cancer 10.6 PGR ESR1 CYP19A1
204 dysphagia 10.6
205 angiocentric glioma 10.6 VIM ACTC1
206 female breast cancer 10.6 PGR ESR1 CYP19A1
207 syringocystadenoma papilliferum 10.6 DES ACTC1
208 aromatase excess syndrome 10.6 ESR2 ESR1 CYP19A1
209 cervical polyp 10.6 PGR DES CD34
210 dermis tumor 10.6 MED12 FH COL4A6
211 pre-malignant neoplasm 10.5 PGR ESR1 CYP19A1
212 benign giant cell tumor 10.5 VIM DES ACTC1
213 metatypical basal cell carcinoma 10.5 PTCH1 CD34
214 biphasic synovial sarcoma 10.5 VIM PGR ESR1 DES
215 syringoma 10.5 VIM S100A1 ESR1
216 skin sarcoma 10.5 FH CD34
217 polyp of corpus uteri 10.5 PGR GNRH1
218 infiltrating angiolipoma 10.5 HMGA2 GNRH1 CD34
219 breast carcinoma in situ 10.5 PGR ESR1 CYP19A1
220 endometrial disease 10.5 PGR GNRH1 ESR1 CYP19A1
221 pediatric liposarcoma 10.5 VIM HMGA2 CD34
222 spiradenoma 10.5 VIM S100A1 ACTC1
223 alveolar soft part sarcoma 10.5 VIM DES ACTC1
224 amelogenesis imperfecta 10.5 PGR ESR2 ESR1 CYP19A1
225 clear cell meningioma 10.5 VIM PGR CD34
226 gender identity disorder 10.5 PGR ESR2 ESR1 CYP19A1
227 progesterone-receptor positive breast cancer 10.5 PGR ESR2 ESR1 CYP19A1
228 myoepithelioma 10.5 VIM S100A1 ACTC1
229 pyogenic granuloma 10.5 CD34 ACTC1
230 lobular neoplasia 10.5 PGR ESR2 ESR1 CYP19A1
231 thoracic benign neoplasm 10.5 PGR MED12 ESR1 CD34
232 primary pigmented nodular adrenocortical disease 10.5 PGR ESR2 ESR1 CYP19A1
233 teeth hard tissue disease 10.5 PGR ESR2 ESR1 CYP19A1
234 breast benign neoplasm 10.5 PGR MED12 ESR1 CD34
235 sporadic breast cancer 10.5 PGR ESR2 ESR1 CYP19A1
236 estrogen-receptor positive breast cancer 10.5 PGR ESR2 ESR1 CYP19A1
237 skin benign neoplasm 10.5 PTCH1 FH CD34
238 ovarian endometrioid stromal sarcoma 10.5 PGR CYP19A1
239 ductal carcinoma in situ 10.5 PGR ESR2 ESR1 CYP19A1
240 47,xyy 10.5
241 chondroid chordoma 10.5 VIM S100A1
242 vaginal adenoma 10.5 ESR2 CYP19A1
243 parachordoma 10.5 VIM S100A1 DES ACTC1
244 ossifying fibromyxoid tumor 10.5 VIM S100A1 DES ACTC1
245 chondromyxoid fibroma 10.5 VIM S100A1 DES ACTC1
246 congenital fibrosarcoma 10.5 VIM S100A1 DES ACTC1
247 sarcomatoid mesothelioma 10.5 VIM S100A1 DES ACTC1
248 bone resorption disease 10.5 ESR2 ESR1 CYP19A1
249 extraskeletal ewing sarcoma 10.4 VIM DES
250 premature ovarian failure 1 10.4 GNRH1 ESR2 ESR1 CYP19A1
251 uterine sarcoma 10.4
252 bone remodeling disease 10.4 ESR2 ESR1 CYP19A1
253 desmoplastic small round cell tumor 10.4 VIM DES
254 spindle cell lipoma 10.4 VIM DES CD34 ACTC1
255 pseudosarcomatous fibromatosis 10.4 VIM DES CD34 ACTC1
256 infantile myofibromatosis 10.4 VIM DES CD34 ACTC1
257 amelogenesis imperfecta, type ig 10.4 PGR GNRH1 ESR2 ESR1 CYP19A1
258 amenorrhea 10.4
259 atypical teratoid rhabdoid tumor 10.4 VIM S100A1 HMGA2 DES ACTC1
260 ovarian disease 10.4 PGR GNRH1 ESR2 ESR1 CYP19A1
261 intussusception 10.4
262 intravascular fasciitis 10.4 ESR1 CD34
263 angiolipoma 10.4 VIM FH DES CD34 ACTC1
264 endometrial cancer 10.3
265 cellular schwannoma 10.3 S100A1 CD34
266 meckel diverticulum 10.3
267 intestinal obstruction 10.3
268 inguinal hernia 10.3
269 pseudo-meigs syndrome 10.3
270 esophageal cancer 10.3
271 insulin-like growth factor i 10.3
272 pericardial mesothelioma 10.3 VIM S100A1
273 glomangioma 10.3 VIM S100A1 DES CD34 ACTC1
274 adenoma 10.3
275 48,xyyy 10.3
276 virus-associated trichodysplasia spinulosa 10.3
277 spindle cell carcinoma 10.3 VIM PGR ESR1 DES CD34 ACTC1
278 hydronephrosis 10.3
279 constipation 10.3
280 kidney cancer 10.3
281 chromosomal triplication 10.3
282 breast cancer 10.2
283 progesterone-receptor negative breast cancer 10.2 PGR ESR1
284 mayer-rokitansky-kuster-hauser syndrome 10.2
285 uterine inversion 10.2
286 back pain 10.2
287 vaginal benign neoplasm 10.2 ESR2 CYP19A1
288 adenocarcinoma 10.2
289 congenital heart defects, hamartomas of tongue, and polysyndactyly 10.2
290 acute cystitis 10.2
291 b-cell lymphoma 10.2
292 placenta praevia 10.2
293 pulmonary fibrosis, idiopathic 10.2 TGFB3 S100A1 CD34 ACTC1
294 volvulus of midgut 10.2
295 tuberous sclerosis 10.2
296 fh tumor predisposition syndrome 10.2
297 immune deficiency disease 10.1
298 deficiency anemia 10.1
299 cardiac arrest 10.1
300 respiratory failure 10.1
301 squamous cell carcinoma 10.1
302 kidney disease 10.1
303 peritonitis 10.1
304 neurofibromatosis 10.1
305 placental abruption 10.1
306 testicular gonadoblastoma 10.1 VIM KIT
307 cribriform carcinoma 10.1 PGR KIT ESR1
308 microglandular adenosis 10.1 PGR KIT ESR1
309 ovarian fibrothecoma 10.1 KIT DES ACTC1
310 thrombophilia due to thrombin defect 10.1
311 lymphoma 10.1
312 severe combined immunodeficiency 10.1
313 appendicitis 10.1
314 achalasia 10.1
315 pulmonary embolism 10.1
316 syncope 10.1
317 rapidly involuting congenital hemangioma 10.1
318 ovarian fibroma 10.1
319 pulmonary vein stenosis 10.1 KIT DES ACTC1
320 spinal cord sarcoma 10.1 KIT CD34
321 tonsil cancer 10.1 PGR KIT ESR1
322 meningioma, radiation-induced 10.1
323 ectopic pregnancy 10.1
324 spinal meningioma 10.1
325 duodenal ulcer 10.1
326 cystic teratoma 10.1
327 secretory meningioma 10.1
328 lymphoplasmacyte-rich meningioma 10.1
329 acquired immunodeficiency syndrome 10.1
330 hypereosinophilic syndrome 10.1
331 liver fibroma 10.1 VIM KIT
332 small intestine leiomyosarcoma 10.1 KIT CD34
333 senile angioma 10.1 VIM KIT
334 kidney benign neoplasm 10.1 S100A1 KIT FH
335 melanoma, uveal 10.0
336 wilms tumor 5 10.0
337 paraganglioma 10.0
338 thrombosis 10.0
339 telangiectasis 10.0
340 iron metabolism disease 10.0
341 prostatic adenoma 10.0
342 trophoblastic neoplasm 10.0
343 urinary tract obstruction 10.0
344 ileus 10.0
345 exophthalmos 10.0
346 mucocele of appendix 10.0 KIT CD34
347 gastric liposarcoma 10.0 KIT CD34
348 adult cystic nephroma 10.0 PGR KIT DES ACTC1
349 gallbladder leiomyosarcoma 10.0 KIT CD34
350 jejunal neoplasm 10.0 KIT CD34
351 plexiform schwannoma 10.0 KIT CD34
352 prostate stromal sarcoma 10.0 PGR KIT CD34
353 vulvar disease 10.0 PGR KIT CD34
354 retroperitoneal hemangiopericytoma 10.0 KIT CD34
355 colon leiomyosarcoma 10.0 KIT CD34
356 paraganglioma and gastric stromal sarcoma 10.0 KIT FH CD34
357 benign perivascular tumor 10.0 KIT CD34
358 bladder cancer 10.0
359 tuberous sclerosis 1 10.0
360 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
361 prostatic hyperplasia, benign 10.0
362 body mass index quantitative trait locus 1 10.0
363 arteriovenous malformation 10.0
364 leukemia 10.0
365 acute kidney failure 10.0
366 multiple endocrine neoplasia 10.0
367 mature teratoma 10.0
368 placenta disease 10.0
369 polycythemia 10.0
370 lung disease 10.0
371 herpes simplex 10.0
372 vasculitis 10.0
373 benign fibrous mesothelioma 10.0 KIT CD34
374 mast-cell sarcoma 10.0 VIM KIT
375 pleomorphic liposarcoma 10.0 VIM KIT DES ACTC1
376 heart sarcoma 10.0 KIT CD34
377 hepatic angiomyolipoma 10.0 KIT CD34
378 cutaneous ganglioneuroma 10.0 KIT CD34
379 myxofibrosarcoma 10.0 KIT DES CD34
380 jejunal atresia 10.0
381 neurofibromatosis, type ii 10.0
382 multiple endocrine neoplasia, type i 10.0
383 hernia, hiatus 10.0
384 kaposi sarcoma 10.0
385 neurofibromatosis, type i 10.0
386 pheochromocytoma 10.0
387 retinal detachment 10.0
388 lymphoma, hodgkin, classic 10.0
389 androgen insensitivity syndrome 10.0
390 ataxia and polyneuropathy, adult-onset 10.0
391 myxoid liposarcoma 10.0
392 gastric cancer 10.0
393 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.0
394 diffuse large b-cell lymphoma 10.0
395 adrenal gland pheochromocytoma 10.0
396 sexual disorder 10.0
397 benign teratoma 10.0
398 endometritis 10.0
399 cholelithiasis 10.0
400 iron deficiency anemia 10.0
401 esophagitis 10.0
402 cystitis 10.0
403 urethral stricture 10.0
404 basal cell carcinoma 10.0
405 transitional cell carcinoma 10.0
406 pleural empyema 10.0
407 ureteral obstruction 10.0
408 adenomatoid tumor 10.0
409 peptic ulcer disease 10.0
410 mixed endometrial stromal and smooth muscle tumor 10.0
411 fumarate hydratase deficiency 10.0
412 dentinogenesis imperfecta type 2 10.0
413 posttransplant acute limbic encephalitis 10.0
414 ring chromosome 10.0
415 monosomy 22 10.0
416 mixed cell type cancer 9.9 PGR KIT ESR1 CD34
417 skeletal muscle cancer 9.9 PTCH1 KIT CD34
418 polymorphous low-grade adenocarcinoma 9.9 VIM S100A1 KIT ACTC1
419 cell type benign neoplasm 9.9 KIT FH ESR1 CD34
420 perineurioma 9.9 VIM S100A1 KIT ACTC1
421 suppression of tumorigenicity 12 9.9 KIT GNRH1 ESR2 ESR1
422 liver leiomyosarcoma 9.9 KIT CD34
423 muscle cancer 9.9 PTCH1 KIT DES CD34
424 gastroesophageal reflux 9.9
425 carpal tunnel syndrome 9.9
426 teratoma, ovarian 9.9
427 pneumothorax, primary spontaneous 9.9
428 uterine anomalies 9.9
429 ataxia-telangiectasia 9.9
430 budd-chiari syndrome 9.9
431 human immunodeficiency virus type 1 9.9
432 preterm premature rupture of the membranes 9.9
433 lung cancer susceptibility 3 9.9
434 gastrointestinal carcinoma 9.9
435 scoliosis 9.9
436 pelvic inflammatory disease 9.9
437 rickets 9.9
438 endosalpingiosis 9.9
439 infant gynecomastia 9.9
440 polycystic ovary syndrome 9.9
441 oligohydramnios 9.9
442 cholestasis 9.9
443 squamous cell papilloma 9.9
444 peptic esophagitis 9.9
445 vascular disease 9.9
446 islet cell tumor 9.9
447 melanoma 9.9
448 vaginitis 9.9
449 gastroenteritis 9.9
450 papilloma 9.9
451 papillary carcinoma 9.9
452 gastrointestinal system cancer 9.9
453 lipomatosis 9.9
454 choriocarcinoma 9.9
455 placental site trophoblastic tumor 9.9
456 amelanotic melanoma 9.9
457 placenta accreta 9.9
458 endometrial stromal tumor 9.9
459 ovarian germ cell teratoma 9.9
460 salpingitis 9.9
461 neuropathy 9.9
462 complete androgen insensitivity syndrome 9.9
463 hypoxia 9.9
464 pituitary tumors 9.9
465 septate uterus 9.9
466 thyroid carcinoma 9.9
467 breast leiomyosarcoma 9.9 KIT CD34
468 mucinous adenocarcinoma 9.9 VIM PGR KIT ESR2 ESR1
469 vaginal endometrial stromal sarcoma 9.8 VIM PGR KIT ESR1 CD34
470 vagina sarcoma 9.8 VIM PGR KIT ESR1 CD34
471 adenosarcoma 9.8 VIM PGR KIT ESR1 DES ACTC1
472 sarcomatous intrahepatic cholangiocarcinoma 9.8 KIT CD34
473 atherosclerosis susceptibility 9.8
474 autoimmune disease 9.8
475 basal cell nevus syndrome 9.8
476 diabetes mellitus, noninsulin-dependent 9.8
477 fibrosis of extraocular muscles, congenital, 1 9.8
478 systemic lupus erythematosus 9.8
479 retinoblastoma 9.8
480 schistosoma mansoni infection, susceptibility/ 9.8
481 thyroid cancer, nonmedullary, 1 9.8
482 down syndrome 9.8
483 varicose veins 9.8
484 vesicoureteral reflux 1 9.8
485 osteogenic sarcoma 9.8
486 pulmonary arteriovenous fistulas 9.8
487 asthma 9.8
488 sickle cell anemia 9.8
489 cervical cancer 9.8
490 cyanosis, transient neonatal 9.8
491 muscle hypertrophy 9.8
492 barrett esophagus 9.8
493 myelodysplastic syndrome 9.8
494 tumor predisposition syndrome 9.8
495 hyperprolactinemia 9.8
496 melanoma, cutaneous malignant 10 9.8
497 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
498 obstructive nephropathy 9.8
499 polycystic kidney disease 9.8
500 osteomyelitis 9.8
501 thalassemia 9.8
502 bacterial infectious disease 9.8
503 disseminated intravascular coagulation 9.8
504 chlamydia 9.8
505 pyelonephritis 9.8
506 nephrotic syndrome 9.8
507 low compliance bladder 9.8
508 hepatic coma 9.8
509 hereditary hemorrhagic telangiectasia 9.8
510 megaesophagus 9.8
511 hepatic encephalopathy 9.8
512 hyperparathyroidism 9.8
513 obstructive jaundice 9.8
514 schistosomiasis 9.8
515 chronic cystitis 9.8
516 pericarditis 9.8
517 impotence 9.8
518 cholecystitis 9.8
519 rectum cancer 9.8
520 gestational choriocarcinoma 9.8
521 intestinal perforation 9.8
522 sertoli-leydig cell tumor 9.8
523 astrocytoma 9.8
524 interstitial lung disease 9.8
525 ischemia 9.8
526 gastric adenocarcinoma 9.8
527 pulmonary fibrosis 9.8
528 pituitary adenoma 9.8
529 gastritis 9.8
530 ciliary body cancer 9.8
531 familial retinoblastoma 9.8
532 congenital mesoblastic nephroma 9.8
533 pulmonary coin lesion 9.8
534 clear cell adenofibroma 9.8
535 cystadenofibroma 9.8
536 pneumonia 9.8
537 acute pyelonephritis 9.8
538 esophageal disease 9.8
539 active peptic ulcer disease 9.8
540 parathyroid adenoma 9.8
541 myeloid leukemia 9.8
542 skin melanoma 9.8
543 autosomal dominant polycystic kidney disease 9.8
544 amyloidosis 9.8
545 urethral diverticulum 9.8
546 hydrocele 9.8
547 hemometra 9.8
548 hypoglycemia 9.8
549 keloid disorder 9.8
550 granulosa cell tumor of the ovary 9.8
551 osteochondroma 9.8
552 polymyositis 9.8
553 pulmonary arteriovenous malformation 9.8
554 ring chromosome 1 9.8
555 nonsyndromic paraganglioma 9.8
556 aneurysm 9.8
557 angiomatosis 9.8
558 encephalopathy 9.8
559 paresthesia 9.8
560 glial tumor 9.8
561 rare lymphatic malformation 9.8
562 argyria 9.8
563 rare benign ovarian tumor 9.8
564 cardiogenic shock 9.8
565 adenoid cystic carcinoma 9.8 VIM S100A1 PGR KIT ACTC1
566 juvenile nasopharyngeal angiofibroma 9.8 TGFB3 PGR KIT ESR1 CYP19A1 ACTC1
567 uterine benign neoplasm 9.8 TGFB3 RAD51B PGR MED12 HMGA2 GNRH1
568 reproductive organ benign neoplasm 9.8 TGFB3 RAD51B PGR MED12 HMGA2 GNRH1
569 dedifferentiated liposarcoma 9.7 S100A1 KIT HMGA2 DES CD34 ACTC1
570 malignant peripheral nerve sheath tumor 9.7 VIM S100A1 KIT HMGA2 CD34 ACTC1
571 angioedema, hereditary, type i 9.7
572 atrial standstill 1 9.7
573 blue rubber bleb nevus 9.7
574 colorectal cancer 9.7
575 congenital anomalies of kidney and urinary tract 2 9.7
576 hypercalcemia, infantile, 1 9.7
577 keloid formation 9.7
578 klippel-trenaunay-weber syndrome 9.7
579 li-fraumeni syndrome 9.7
580 myositis 9.7
581 otitis media 9.7
582 mccune-albright syndrome 9.7
583 familial adenomatous polyposis 1 9.7
584 peutz-jeghers syndrome 9.7
585 prostate cancer 9.7
586 dowling-degos disease 1 9.7
587 sarcoidosis 1 9.7
588 schizophrenia 1 9.7
589 strabismus 9.7
590 chromosome 2q35 duplication syndrome 9.7
591 testicular torsion 9.7
592 trigeminal neuralgia 9.7
593 ureterocele 9.7
594 renal hypodysplasia/aplasia 1 9.7
595 lipoid congenital adrenal hyperplasia 9.7
596 afibrinogenemia, congenital 9.7
597 lung cancer 9.7
598 celiac disease 1 9.7
599 chondrosarcoma 9.7
600 galactorrhea 9.7
601 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.7
602 myasthenia gravis 9.7
603 pancreatic cancer 9.7
604 pituitary hormone deficiency, combined, 2 9.7
605 vascular hyalinosis 9.7
606 spondylocostal dysostosis 1, autosomal recessive 9.7
607 xeroderma pigmentosum, complementation group a 9.7
608 xeroderma pigmentosum, variant type 9.7
609 alpha-thalassemia/mental retardation syndrome, x-linked 9.7
610 focal dermal hypoplasia 9.7
611 aging 9.7
612 gallbladder disease 1 9.7
613 dermatitis herpetiformis, familial 9.7
614 branchiootic syndrome 1 9.7
615 astigmatism 9.7
616 ventricular fibrillation, paroxysmal familial, 1 9.7
617 alpha-thalassemia 9.7
618 carney triad 9.7
619 becker nevus syndrome 9.7
620 lymphoma, non-hodgkin, familial 9.7
621 nephronophthisis 4 9.7
622 anxiety 9.7
623 autoimmune disease 1 9.7
624 mycobacterium tuberculosis 1 9.7
625 leukemia, chronic myeloid 9.7
626 myocardial infarction 9.7
627 li-fraumeni syndrome 2 9.7
628 spondylocostal dysostosis 3, autosomal recessive 9.7
629 cone-rod synaptic disorder, congenital nonprogressive 9.7
630 testicular microlithiasis 9.7
631 tuberous sclerosis 2 9.7
632 accelerated tumor formation 9.7
633 membranous nephropathy 9.7
634 human herpesvirus 8 9.7
635 pulmonary hypertension, primary, 3 9.7
636 leukemia, acute lymphoblastic 3 9.7
637 carbonic anhydrase va deficiency, hyperammonemia due to 9.7
638 lung disease, immunodeficiency, and chromosome breakage syndrome 9.7
639 alkuraya-kucinskas syndrome 9.7
640 central centrifugal cicatricial alopecia 9.7
641 angina pectoris 9.7
642 adrenal cortical carcinoma 9.7
643 lambert-eaton myasthenic syndrome 9.7
644 hypophosphatemia 9.7
645 familial adenomatous polyposis 9.7
646 extrapulmonary tuberculosis 9.7
647 persistent mullerian duct syndrome 9.7
648 atrioventricular block 9.7
649 limb ischemia 9.7
650 villous adenoma 9.7
651 colitis 9.7
652 bone disease 9.7
653 lymphoblastic lymphoma 9.7
654 ovarian sex-cord stromal tumor 9.7
655 bone sarcoma 9.7
656 aortic dissection 9.7
657 multicentric castleman disease 9.7
658 castleman disease 9.7
659 subglottis neoplasm 9.7
660 endocarditis 9.7
661 secondary hypertrophic osteoarthropathy 9.7
662 esophageal atresia 9.7
663 intestinal atresia 9.7
664 pre-eclampsia 9.7
665 microphthalmia 9.7
666 portal hypertension 9.7
667 premature menopause 9.7
668 gastric ulcer 9.7
669 abducens nerve disease 9.7
670 hypospadias 9.7
671 microcephaly 9.7
672 cholesteatoma of middle ear 9.7
673 hemiplegia 9.7
674 alport syndrome 9.7
675 enophthalmos 9.7
676 primary hyperparathyroidism 9.7
677 cauda equina syndrome 9.7
678 portal vein thrombosis 9.7
679 gestational diabetes 9.7
680 hypertrophic cardiomyopathy 9.7
681 chagas disease 9.7
682 radial neuropathy 9.7
683 goiter 9.7
684 von willebrand's disease 9.7
685 quadriplegia 9.7
686 uveitis 9.7
687 esophageal diverticulosis 9.7
688 tooth resorption 9.7
689 diarrhea 9.7
690 ehlers-danlos syndrome 9.7
691 megaloblastic anemia 9.7
692 pulmonary sarcoidosis 9.7
693 endometrial stromal nodule 9.7
694 facial paralysis 9.7
695 toxic shock syndrome 9.7
696 46 xx gonadal dysgenesis 9.7
697 dumping syndrome 9.7
698 hypothyroidism 9.7
699 hereditary angioedema 9.7
700 echinococcosis 9.7
701 chronic cervicitis 9.7
702 urticaria 9.7
703 thrombocytopenia 9.7
704 lymphadenitis 9.7
705 keratosis 9.7
706 neovascular glaucoma 9.7
707 neuroendocrine tumor 9.7
708 ichthyosis 9.7
709 vascular cancer 9.7
710 ocular melanoma 9.7
711 neuroendocrine carcinoma 9.7
712 calcinosis 9.7
713 hepatitis c 9.7
714 viral hepatitis 9.7
715 hypogonadism 9.7
716 dysostosis 9.7
717 thymus lipoma 9.7
718 autoimmune hepatitis 9.7
719 hyperostosis 9.7
720 heel spur 9.7
721 hemorrhagic disease 9.7
722 thrombocytosis 9.7
723 acromegaly 9.7
724 angiodysplasia 9.7
725 cervicitis 9.7
726 ovarian brenner tumor 9.7
727 benign mesothelioma 9.7
728 adenofibroma 9.7
729 dermatitis 9.7
730 middle lobe syndrome 9.7
731 cervix carcinoma 9.7
732 glomerulonephritis 9.7
733 iga glomerulonephritis 9.7
734 antiphospholipid syndrome 9.7
735 gingival overgrowth 9.7
736 papillary adenocarcinoma 9.7
737 gallbladder cancer 9.7
738 inverted papilloma 9.7
739 neurilemmomatosis 9.7
740 purpura 9.7
741 mammary paget's disease 9.7
742 cellulitis 9.7
743 turner syndrome 9.7
744 pseudomyxoma peritonei 9.7
745 aortic aneurysm 9.7
746 empty sella syndrome 9.7
747 bladder disease 9.7
748 plexopathy 9.7
749 fallopian tube adenocarcinoma 9.7
750 esophagus squamous cell carcinoma 9.7
751 seminal vesicle tumor 9.7
752 thrombophlebitis 9.7
753 lynch syndrome 9.7
754 diffuse lipomatosis 9.7
755 bartholin's gland carcinoma 9.7
756 eosinophilic gastritis 9.7
757 eosinophilic gastroenteritis 9.7
758 tricuspid valve stenosis 9.7
759 tricuspid valve insufficiency 9.7
760 radiculopathy 9.7
761 polyradiculopathy 9.7
762 non-gestational choriocarcinoma 9.7
763 lymphocele 9.7
764 intracranial embolism 9.7
765 pustulosis of palm and sole 9.7
766 seminoma 9.7
767 sarcomatoid renal cell carcinoma 9.7
768 rhinitis 9.7
769 bile duct cancer 9.7
770 ulnar neuropathy 9.7
771 holoprosencephaly 9.7
772 epicardium cancer 9.7
773 adenosquamous carcinoma 9.7
774 klatskin's tumor 9.7
775 liver cirrhosis 9.7
776 plexiform neurofibroma 9.7
777 uterine corpus sarcoma 9.7
778 lung leiomyosarcoma 9.7
779 small intestinal sarcoma 9.7
780 vagina leiomyosarcoma 9.7
781 kidney leiomyosarcoma 9.7
782 pituitary gland disease 9.7
783 congestive heart failure 9.7
784 bronchitis 9.7
785 pulmonary valve stenosis 9.7
786 malignant ciliary body melanoma 9.7
787 myositis ossificans 9.7
788 spinal stenosis 9.7
789 parasagittal meningioma 9.7
790 malignant iris melanoma 9.7
791 multicentric papillary thyroid carcinoma 9.7
792 cystitis cystica 9.7
793 thyroiditis 9.7
794 esophageal tuberculosis 9.7
795 diverticulitis 9.7
796 sarcomatosis 9.7
797 chronic kidney disease 9.7
798 cataract 9.7
799 meckel's diverticulitis 9.7
800 actinomycosis 9.7
801 dermatitis herpetiformis 9.7
802 herpes zoster 9.7
803 reticulosarcoma 9.7
804 ulcerative colitis 9.7
805 myeloid sarcoma 9.7
806 lupus erythematosus 9.7
807 psoriasis 9.7
808 gas gangrene 9.7
809 mechanical strabismus 9.7
810 nasal cavity benign neoplasm 9.7
811 hypopituitarism 9.7
812 cholangitis 9.7
813 dacryoadenitis 9.7
814 bronchiectasis 9.7
815 plantar fasciitis 9.7
816 alopecia 9.7
817 meibomian cyst 9.7
818 spondylocostal dysostosis, autosomal recessive 9.7
819 basal cell carcinoma, multiple 9.7
820 bronchogenic cyst 9.7
821 cerebrospinal fluid leak 9.7
822 chromophil renal cell carcinoma 9.7
823 cytokine deficiency 9.7
824 erythrokeratoderma ''en cocardes'' 9.7
825 glioma 9.7
826 goblet cell carcinoid 9.7
827 gynandroblastoma 9.7
828 hemangioendothelioma 9.7
829 leukoplakia 9.7
830 pancreatic adenoma 9.7
831 plasmablastic lymphoma 9.7
832 precocious puberty 9.7
833 pulmonary sequestration 9.7
834 pure autonomic failure 9.7
835 ring chromosome 12 9.7
836 soft tissue sarcoma 9.7
837 spitz nevus 9.7
838 superficial spreading melanoma 9.7
839 urachal cyst 9.7
840 urethral cancer 9.7
841 9q22.3 microdeletion 9.7
842 chronic pain 9.7
843 head injury 9.7
844 headache 9.7
845 hypotonia 9.7
846 rare tumor of pancreas 9.7
847 longitudinal vaginal septum 9.7
848 adrenogenital syndrome 9.7
849 cerebrofacial arteriovenous metameric syndrome 9.7
850 epithelioid hemangioendothelioma 9.7
851 muscular tumor 9.7
852 specific language disorder 9.7
853 multilocular cystic renal neoplasm of low malignant potential 9.7
854 pre-descemet corneal dystrophy 9.7
855 atypical meigs syndrome 9.7
856 primary eosinophilic gastrointestinal disease 9.7
857 eosinophilic colitis 9.7
858 keratocystic odontogenic tumor 9.7
859 congenital amyoplasia 9.7
860 rare soft tissue tumor 9.7
861 adenoma of pancreas 9.7
862 nodular lymphocyte predominant hodgkin lymphoma 9.7
863 rare gynecological tumor 9.7
864 polyploidy 9.7
865 overgrowth syndrome 9.7
866 alobar holoprosencephaly 9.7
867 rare renal tumor 9.7
868 azygos continuation of the inferior vena cava 9.7
869 intestinal polyposis syndrome 9.7
870 esophageal duplication cyst 9.7
871 uterine carcinosarcoma 9.6 VIM S100A1 PGR KIT ESR2 ESR1

Graphical network of the top 20 diseases related to Leiomyoma:



Diseases related to Leiomyoma

Symptoms & Phenotypes for Leiomyoma

UMLS symptoms related to Leiomyoma:


pelvic pain

GenomeRNAi Phenotypes related to Leiomyoma according to GeneCards Suite gene sharing:

26 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.92 ESR1 ESR2 FH RAD51B

MGI Mouse Phenotypes related to Leiomyoma:

45 (showing 9, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.28 ACTC1 CD34 CYP19A1 DES ESR1 ESR2
2 homeostasis/metabolism MP:0005376 10.25 ACTC1 CD34 CYP19A1 DES ESR1 ESR2
3 cardiovascular system MP:0005385 10.23 ACTC1 CYP19A1 DES ESR1 ESR2 KIT
4 integument MP:0010771 10.02 CD34 CYP19A1 DPT ESR1 ESR2 GNRH1
5 muscle MP:0005369 9.96 ACTC1 CYP19A1 DES ESR1 ESR2 KIT
6 limbs/digits/tail MP:0005371 9.87 ESR1 ESR2 KIT MED12 PGR PTCH1
7 normal MP:0002873 9.73 ACTC1 COL4A6 CYP19A1 ESR1 ESR2 GNRH1
8 neoplasm MP:0002006 9.7 CD34 ESR1 ESR2 GNRH1 KIT PGR
9 skeleton MP:0005390 9.28 CYP19A1 ESR1 ESR2 GNRH1 KIT MED12

Drugs & Therapeutics for Leiomyoma

Drugs for Leiomyoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 236, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Anastrozole Approved, Investigational Phase 4 120511-73-1 2187
2
Dienogest Approved Phase 4 65928-58-7
3
Desogestrel Approved Phase 4 54024-22-5 40973
4
Ferrous fumarate Approved Phase 4 141-01-5
5
Methylcobalamin Approved, Investigational Phase 4 13422-55-4
6
leucovorin Approved Phase 4 58-05-9 6006 143
7
Zinc Approved, Investigational Phase 4 7440-66-6 32051
8
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
9
Hydroxocobalamin Approved Phase 4 13422-51-0 15589840 11953898
10
Zinc oxide Approved Phase 4 1314-13-2
11
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
12
Calcium carbonate Approved, Investigational Phase 4 471-34-1
13
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
14
Ibuprofen Approved Phase 4 15687-27-1 3672
15
Dinoprostone Approved Phase 4 363-24-6 5280360
16
Goserelin Approved Phase 4 65807-02-5 5311128 47725
17
Remifentanil Approved Phase 4 132875-61-7 60815
18
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
19
Prilocaine Approved Phase 4 721-50-6 4906
20
Morphine Approved, Investigational Phase 4 57-27-2 5288826
21
Misoprostol Approved Phase 4 59122-46-2 5282381
22
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
23
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
24
Sirolimus Approved, Investigational Phase 4 53123-88-9 5284616 6436030 46835353
25
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
26
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
27
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
28
Polyestradiol phosphate Approved Phase 4 28014-46-2
29
Oxytocin Approved, Vet_approved Phase 4 50-56-6 53477758 439302
30
Letrozole Approved, Investigational Phase 4 112809-51-5 3902
31
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
32
Mifepristone Approved, Investigational Phase 4 84371-65-3 55245
33
Leuprolide Approved, Investigational Phase 4 53714-56-0 657181 3911
34
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
35
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
36
Pregabalin Approved, Investigational Phase 4 148553-50-8 5486971
37
Medroxyprogesterone acetate Approved, Investigational Phase 4 71-58-9
38
Glycine Approved, Nutraceutical, Vet_approved Phase 4 56-40-6 750
39
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221